FDA Resources

Gao ID: PEMD-96-8R April 23, 1996

Pursuant to a congressional request, GAO reviewed the Food and Drug Administration's (FDA) resource allocation, workload, and review time for biologics, human drugs, medical devices, food additives, and animal drugs. GAO noted that: (1) the amount of resources needed for each application review varies by product type; (2) in general, review times are shorter for application reviews that require fewer resources; (3) resource allocation also varies by each review center's product mix at any given time; and (4) FDA has initiated a number of changes to increase the efficiency of its product review process, but their effectiveness are not yet known.



The Justia Government Accountability Office site republishes public reports retrieved from the U.S. GAO These reports should not be considered official, and do not necessarily reflect the views of Justia.